We previously communicated that the changes
detailed below would be made to the list of services and drugs that require
precertification for most commercial AmeriHealth New Jersey members effective
for dates of service on or after June 1, 2012.* Please
note that these changes will now go into effect for dates of service on or
after July 1, 2012.
The following
precertification requirements are being added in all settings effective for
dates of service on or after July 1, 2012:
- potentially cosmetic
procedures (please refer to the complete list below);
- pain management procedures
(paravertebral facet joint injections, transforaminal epidural injections,
epidural injections);
- additional medical
infusion/injectable drugs (please refer to the complete list below);
- cataract surgery;
- cochlear implant surgery;
- hyperbaric oxygen;
- uvulopalatopharyngoplasty (UPPP or
UP3).
The following
precertification requirements are being removed in all settings effective for
dates of service on or after July 1, 2012:
- sleep studies
- cardiac rehabilitation
- pulmonary
rehabilitation
Cardiac radiology services
We also communicated that we will
require precertification for cardiac radiology services (stress
echocardiography, resting transthoracic echocardiography, and transesophageal
echocardiography) for most commercial AmeriHealth New Jersey members effective
for dates of service on or after June 1, 2012.*
Please note that we will allow a 30-day
grace period for enforcement of these new precertification requirements, and
providers will be required to observe these updated precertification
requirements for dates of service on or after July 1, 2012. However, providers
can begin to submit precertification requests for these services as of June 1,
2012.
It is very important that providers
verify member-specific requirements using the NaviNet? web portal or by referring to the most current
precertification requirement lists on our website. Failure to
obtain precertification for any of the services or drugs that require it for
dates of service on or after July 1, 2012, may result in a reduction in payment
or nonpayment for the services not precertified.
Please call Customer Service at 1-800-275-2583 if you have any questions about these
changes to precertification requirements.
|
Blepharoplasty/ptsosis repair
|
Hair transplant
|
Rhinoplasty
|
Breast: reconstruction, reduction,
augmentation, mammoplasty, mastopexy, insertion, and removal of breast
implants
|
Injectable dermal fillers
|
Rhytidectomy
|
Canthopexy/canthoplasty
|
Keloid removal
|
Scar revision
|
Cervicoplasty
|
Labiaplasty
|
Sex reassignment surgery
|
Chemical peels
|
Lipectomy, liposuction, or any other
excess fat removal procedure
|
Skin closures including: skin
grafts, skin flaps, and tissue grafts
|
Dermabrasion
|
Orthognathic surgery procedures
including, but not limited to: bone graft, genioplasty, osteoplasty,
mentoplasty, osteotomies
|
Surgery for varicose veins,
including perforators and sclerotherapy
|
Excision of excessive skin and/or
subcutaneous tissue
|
Otoplasty
|
Surgical treatment of
gynecomastia
|
Genetically and bio-engineered skin
substitutes for wound care
|
|
|
Abraxane?
|
Flolan?
|
Jevtana?
|
Alimta?
|
Folotyn?
|
Nulojix?
|
Alpha 1 inhibitors (Aralast NPTM, GlassiaTM,
Prolastin? C, Zemaira?)
|
Gammaplex? (IVIG)
|
Provenge?
|
ArzerraTM
|
HalavenTM
|
Psoriasis/rheumatoid arthritis
(Actemra?)
|
Benlysta?
|
Hemophilia factors
|
Remodulin?
|
C1 esterase inhibitors
(Berinert?, Cinryze?)
|
Herceptin? DM1*
|
Soliris?
|
Enzyme replacement (ElelysoTM, Lumizyme?,
Replagal?**, VPRIV?)
|
Istodax?
|
YervoyTM
|
|
Kalbitor?
|
MakenaTM
|
Stelara?
|
Lucentis?
|
OmaproTM*
|
XgevaTM
|
Macugen?
|
Prolia?
|
Xolair?
|
NaviNet® is a registered trademark of
NaviNet, Inc.